Growth Hormone Deficiency - Pipeline Review, H1 2015

Publisher Name :
Date: 22-Jan-2015
No. of pages: 110
Inquire Before Buying

Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H1 2015', provides an overview of the Growth Hormone Deficiency's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global therapeutic landscape of Growth Hormone Deficiency

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Growth Hormone Deficiency and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Growth Hormone Deficiency products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Growth Hormone Deficiency pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products


Reasons to Buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Growth Hormone Deficiency

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Growth Hormone Deficiency pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Growth Hormone Deficiency - Pipeline Review, H1 2015

Table of Contents

Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Growth Hormone Deficiency Overview 9
Therapeutics Development 10
Pipeline Products for Growth Hormone Deficiency - Overview 10
Pipeline Products for Growth Hormone Deficiency - Comparative Analysis 11
Growth Hormone Deficiency - Therapeutics under Development by Companies 12
Growth Hormone Deficiency - Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Growth Hormone Deficiency - Products under Development by Companies 19
Growth Hormone Deficiency - Companies Involved in Therapeutics Development 21
Aeterna Zentaris Inc. 21
Aileron Therapeutics, Inc. 22
Ascendis Pharma A/S 23
Biogenomics Limited 24
Bolder Biotechnology, Inc. 25
Braasch Biotech LLC 26
CJ CheilJedang Corp. 27
Critical Pharmaceuticals Limited 28
Delpor, Inc. 29
Emisphere Technologies, Inc. 30
Flamel Technologies S.A. 31
Genexine, Inc. 32
HanAll Biopharma Co., Ltd. 33
Hanmi Pharmaceuticals, Co. Ltd. 34
Inbiopro Solutions Pvt. Ltd. 35
LG Life Sciences, Ltd. 36
OPKO Health, Inc. 37
Pfenex Inc. 38
Prometheon Pharma, LLC 39
Teva Pharmaceutical Industries Limited 40
Versartis, Inc. 41
XL-protein GmbH 42
Growth Hormone Deficiency - Therapeutics Assessment 43
Assessment by Monotherapy Products 43
Assessment by Target 44
Assessment by Mechanism of Action 46
Assessment by Route of Administration 48
Assessment by Molecule Type 50
Drug Profiles 52
ACP-001 - Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
albutropin - Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
ALRN-5281 - Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
BBT-031 - Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
CJ-40002 - Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
CP-016 - Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
GXH-9 - Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
HL-032 - Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
HM-10560A - Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
IBPB-003HH - Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
macimorelin acetate - Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
MOD-4023 - Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Pegylated Somatropin - Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
somatropin - Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
somatropin - Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
somatropin - Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
somatropin - Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
somatropin biobetter - Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
somatropin biobetter - Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
somatropin biosimilar - Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
somatropin biosimilar - Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
somatropin pegol - Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
somatropin SR - Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
somatropin true patch - Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
SYN-20100504RU - Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Vaccine for Growth Hormone Deficiencies - Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
XL-020 - Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Growth Hormone Deficiency - Recent Pipeline Updates 87
Growth Hormone Deficiency - - Dormant Projects 100
Growth Hormone Deficiency - Discontinued Products 101
Growth Hormone Deficiency - Product Development Milestones 102
Featured News & Press Releases 102
Dec 29, 2014: Versartis to Hold Conference Call to Discuss VRS-317 Clinical Update From Ongoing Extension Study 102
Dec 15, 2014: Ascendis Pharma Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 102
Oct 30, 2014: Versartis Schedules Conference Call to Discuss Plans for Phase 3 Trial for VRS-317 in Pediatric Growth Hormone Deficiency Patients 103
Sep 18, 2014: Prometheon's CEO/CSO Invited to Deliver Oral Presentation at the European Society for Paediatric Endocrinology Meeting 104
Sep 16, 2014: Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 104
Sep 11, 2014: Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference 105
Jun 30, 2014: Amunix Congratulates Versartis on Its Positive Phase 2a Results With VRS-317 105
Jun 27, 2014: OPKO Granted Patent from European Patent Office for Lagova 106
Jun 25, 2014: Strong Data from Lagova Phase II Clinical Study Presented during Webcast 106
Jun 23, 2014: OPKO Announces Positive Interim Six-Month Lagova (hGH-CTP) Phase 2 Data in Pediatric Growth Hormone Deficiency Disorder 107
Appendix 109
Methodology 109
Coverage 109
Secondary Research 109
Primary Research 109
Expert Panel Validation 109
Contact Us 110
Disclaimer 110

List of Tables

Number of Products under Development for Growth Hormone Deficiency, H1 2015 10
Number of Products under Development for Growth Hormone Deficiency - Comparative Analysis, H1 2015 11
Number of Products under Development by Companies, H1 2015 13
Number of Products under Development by Companies, H1 2015 (Contd..1) 14
Comparative Analysis by Late Stage Development, H1 2015 15
Comparative Analysis by Clinical Stage Development, H1 2015 16
Comparative Analysis by Early Stage Development, H1 2015 17
Comparative Analysis by Unknown Stage Development, H1 2015 18
Products under Development by Companies, H1 2015 19
Products under Development by Companies, H1 2015 (Contd..1) 20
Growth Hormone Deficiency - Pipeline by Aeterna Zentaris Inc., H1 2015 21
Growth Hormone Deficiency - Pipeline by Aileron Therapeutics, Inc., H1 2015 22
Growth Hormone Deficiency - Pipeline by Ascendis Pharma A/S, H1 2015 23
Growth Hormone Deficiency - Pipeline by Biogenomics Limited, H1 2015 24
Growth Hormone Deficiency - Pipeline by Bolder Biotechnology, Inc., H1 2015 25
Growth Hormone Deficiency - Pipeline by Braasch Biotech LLC, H1 2015 26
Growth Hormone Deficiency - Pipeline by CJ CheilJedang Corp., H1 2015 27
Growth Hormone Deficiency - Pipeline by Critical Pharmaceuticals Limited, H1 2015 28
Growth Hormone Deficiency - Pipeline by Delpor, Inc., H1 2015 29
Growth Hormone Deficiency - Pipeline by Emisphere Technologies, Inc., H1 2015 30
Growth Hormone Deficiency - Pipeline by Flamel Technologies S.A., H1 2015 31
Growth Hormone Deficiency - Pipeline by Genexine, Inc., H1 2015 32
Growth Hormone Deficiency - Pipeline by HanAll Biopharma Co., Ltd., H1 2015 33
Growth Hormone Deficiency - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015 34
Growth Hormone Deficiency - Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015 35
Growth Hormone Deficiency - Pipeline by LG Life Sciences, Ltd., H1 2015 36
Growth Hormone Deficiency - Pipeline by OPKO Health, Inc., H1 2015 37
Growth Hormone Deficiency - Pipeline by Pfenex Inc., H1 2015 38
Growth Hormone Deficiency - Pipeline by Prometheon Pharma, LLC, H1 2015 39
Growth Hormone Deficiency - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015 40
Growth Hormone Deficiency - Pipeline by Versartis, Inc., H1 2015 41
Growth Hormone Deficiency - Pipeline by XL-protein GmbH, H1 2015 42
Assessment by Monotherapy Products, H1 2015 43
Number of Products by Stage and Target, H1 2015 45
Number of Products by Stage and Mechanism of Action, H1 2015 47
Number of Products by Stage and Route of Administration, H1 2015 49
Number of Products by Stage and Molecule Type, H1 2015 51
Growth Hormone Deficiency Therapeutics - Recent Pipeline Updates, H1 2015 87
Growth Hormone Deficiency - Dormant Projects, H1 2015 100
Growth Hormone Deficiency - Discontinued Products, H1 2015 101

List of Figures

Number of Products under Development for Growth Hormone Deficiency, H1 2015 10
Number of Products under Development for Growth Hormone Deficiency - Comparative Analysis, H1 2015 11
Number of Products under Development by Companies, H1 2015 12
Comparative Analysis by Late Stage Development, H1 2015 15
Comparative Analysis by Clinical Stage Development, H1 2015 16
Comparative Analysis by Early Stage Products, H1 2015 17
Assessment by Monotherapy Products, H1 2015 43
Number of Products by Top 10 Targets, H1 2015 44
Number of Products by Stage and Top 10 Targets, H1 2015 44
Number of Products by Top 10 Mechanism of Actions, H1 2015 46
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 47
Number of Products by Top 10 Routes of Administration, H1 2015 48
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 49
Number of Products by Top 10 Molecule Types, H1 2015 50
Number of Products by Stage and Top 10 Molecule Types, H1 2015 51

  • Global Anti-inflammatory Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 25-Feb-2020        Price: US 3900 Onwards        Pages: 99
    This report focuses on the global Anti-inflammatory Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-inflammatory Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AbbVie - Johnson & Johnson - Amgen Inc - AstraZeneca PLC - Pfizer, Inc - Novartis - ......
  • Global Virus Like Particles Market Data Survey Report 2015-2025
    Published: 22-Feb-2020        Price: US 1500 Onwards        Pages: 68
    Summary The global Virus Like Particles market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company......
  • Global Varicose Vein Treatment Market Data Survey Report 2015-2025
    Published: 21-Feb-2020        Price: US 1500 Onwards        Pages: 61
    Summary There are several treatment options for Varicose Veins, wearing support stockings, Varicose Vein Treatment Devices; endogenous laser treatment, radiofrequency occlusion, surgery, and lasers and intense pulsed light. Mentioning medical devices for treating Varicose Veins, there is mainly Laser devices, Trivex and RFITT system. The global Varicose Vein Treatment market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report......
  • Global Venous Leg Ulcers Treatment Market Data Survey Report 2015-2025
    Published: 21-Feb-2020        Price: US 1500 Onwards        Pages: 65
    Summary The global Venous Leg Ulcers Treatment market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on ......
  • Global Venous Thromboembolism Therapeutics Market Data Survey Report 2015-2025
    Published: 21-Feb-2020        Price: US 1500 Onwards        Pages: 62
    Summary The global Venous Thromboembolism Therapeutics market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included b......
  • Global Liver Disease Treatment Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 20-Feb-2020        Price: US 2980 Onwards        Pages: 81
    Snapshot The global Liver Disease Treatment market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Liver Disease Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Global Hormone Replacement Therapy Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 20-Feb-2020        Price: US 2980 Onwards        Pages: 76
    Snapshot The global Hormone Replacement Therapy market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hormone Replacement Therapy by product, region and application, in addition, this report introduces market competition situation among the ......
  • Global Plasma Therapy Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 20-Feb-2020        Price: US 2980 Onwards        Pages: 80
    Snapshot The global Plasma Therapy market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Plasma Therapy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profil......
  • Global Thyroid Gland Disorder Treatment Market Data Survey Report 2015-2025
    Published: 19-Feb-2020        Price: US 1500 Onwards        Pages: 61
    Summary The global Thyroid Gland Disorder Treatment market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on com......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs